公开资料显示，轻松健康集团提供健康及保险解决方案，业务包括早筛、健康管理、健康保险以及提供 科普知识和医学研究支持等全流程服务。公司致力于通过一套易用、精准且可负担的健康解决方案，为 有需要的人提供保障和支持。 根据沙利文报告资料，按2024年收入计，公司于中国数字综合健康服务及健康保险服务市场排名第10 位，在中国数字健康服务市场排名第7。轻松健康前身为"轻松筹"，当时是内地主要线上疾病众筹平台 之一，2016年取得保险经纪牌照，2019年更名为轻松健康集团，业务涵盖轻松保、轻松筹、轻松公益及 轻松健康等多个领域。 轻松健康(02661)首挂上市，公告显示，每股定价22.68港元，共发行2654万股股份，每手200股，所得款 项净额约5.13亿港元。截至发稿，涨120.46%，报50港元，成交额1.38亿港元。 ...

Core Viewpoint - The digital health service provider, Easy Health (stock code: 02661.HK), made a strong debut on the Hong Kong Stock Exchange, opening at HKD 50, a significant increase of 120.46% from its issue price of HKD 22.68, reflecting high investor interest and demand [1][2]. Company Overview - Easy Health offers comprehensive digital health services and health insurance solutions in China, including disease screening promotion, health check consultation, medical appointment services, and health product sales, primarily reaching individual users through online platforms [3]. - According to a report by Sullivan, Easy Health ranks tenth in the Chinese digital comprehensive health services and health insurance market based on revenue for 2024, and seventh in the segmented digital health services market [3]. Financial Performance - The company's revenue has shown rapid growth, increasing from RMB 394 million in 2022 to RMB 945 million in 2024, representing a growth of over 140% within two years [3]. - Although the adjusted net profit fluctuated during this period, decreasing from RMB 149 million in 2022 to RMB 84 million in 2024, the financial data for the first half of 2025 indicates a recovery, with revenue reaching RMB 656 million and adjusted net profit at RMB 51 million [3].

财务数据同样亮眼，2024年公司营收同比增长92.9%至9.45亿元，2025年上半年营收再增84.7%至6.56亿 元，健康服务业务收入占比已达76.7%，成为绝对核心增长引擎。在当前港股新股市场分化加剧、稀缺 性标的受追捧的背景下，轻松健康集团凭借"AI技术+用户规模+业务闭环"的独特优势，成功吸引资金 聚焦，为后续股价表现奠定基础。保荐机构表示，公司所处赛道契合"健康中国"战略，未来增长确定性 强，有望成为港股数字健康板块的核心配置标的。 智通财经APP获悉，12月23日，国内"AI+健康"赛道标杆企业轻松健康集团(02661)正式登陆港交所主 板。受市场对数字健康赛道的强烈看好及公司基本面支撑，股价开盘即迎来强势表现，开盘价报50港 元，较发行价高开120%。 作为港股市场稀缺的"全链条数字健康"标的，轻松健康集团的亮眼表现源于多重核心优势。用户层面， 平台累计注册用户已达1.684亿，其中60.4%为20-45岁核心健康消费群体，用户基础为业绩增长提供坚 实支撑。技术层面，自主研发的AIcare技术栈已广泛应用于内容创作、智能承保、理赔审核等核心场 景，AI模型贡献的线索价值持续提升，技术赋能成效显 ...

12月22日，港股新股轻松健康集团(02661)暗盘交易正式启动，开盘即迎来强势拉升，延续招股阶段的 火爆热度。截至暗盘交易时段，公司股价较发行价大涨超110%，市值逼近百亿，成为近期港股暗盘市 场的亮眼标的。 据悉，轻松健康将于12月23日正式在香港联交所主板挂牌上市。本次IPO募资将重点用于AI技术升级、 健康服务场景拓展及产业链整合，持续深化"检-医-药-康-险"生态闭环。业内人士表示，在数字健康产 业万亿市场空间加持下，公司凭借稀缺商业模式与突出竞争优势，上市后有望持续受到资金关注，为投 资者带来长期回报。 暗盘交易作为港股新股正式上市前的场外交易环节，其表现被视为新股上市首日走势的重要风向标。轻 松健康暗盘的大幅高开，印证了资本市场对其"AI+全链条数字健康"模式的坚定信心。此前公司全球招 股超额认购倍数高达1421倍。 市场热度背后，是公司扎实的核心竞争力支撑。作为国内领先的综合数字健康平台，轻松健康累计注册 用户达1.684亿，60.4%为20-45岁核心消费群体，用户第13个月留存率高达92.2%。AI技术深度赋能全业 务链条，自研AIcare技术栈贡献线索价值占比超21%。同时，公司业务结构 ...

Group 1 - The core viewpoint of the article highlights the successful IPO of Easy Health (02661), which received a subscription of HKD 620.4 billion from brokers, resulting in an oversubscription of 1029.8 times against a public offering amount of HKD 60.19 million [1] - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company is expected to be listed on December 23, with CICC and China Merchants Securities International as joint sponsors [1] Group 2 - Easy Health, established in 2014, provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - According to a report by Sullivan, Easy Health ranks 10th in China's digital integrated health services and health insurance market based on projected revenue for 2024, and 7th in the digital health services market [1] - The company, formerly known as "Qing Song Chou," transitioned from being a major online disease crowdfunding platform to a health service provider, obtaining an insurance brokerage license in 2016 and rebranding in 2019 [1] Group 3 - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing a total investment of RMB 100 million, which translates to 4.8018 million shares at the offering price of HKD 22.68 per share [2] - Financial projections indicate that Easy Health expects revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025, respectively, with corresponding profits of RMB 73.616 million, RMB 10.398 million, and RMB 86.045 million [2] - The net proceeds from the fundraising will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total subscription amount of HKD 620.4 billion, leading to an oversubscription rate of 1029.8 times [1] Group 1: IPO Details - The company plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The minimum investment for one lot of shares (200 shares) is HKD 4,581.8, and the company is expected to be listed on December 23 [1] - CICC and China Merchants Securities International are the joint sponsors for the IPO [1] Group 2: Company Background - Easy Health Group was established in 2014, providing comprehensive health and insurance solutions, including early screening, health management, health insurance, and medical research support [1] - The company aims to offer accessible, precise, and affordable health solutions to those in need [1] - Originally known as "Qing Song Chou," the company transitioned to Easy Health Group in 2019, expanding its services across various sectors [1] Group 3: Financial Performance - For the fiscal years ending June 30, 2023, 2024, and 2025, the company reported revenues of approximately RMB 490 million, RMB 945 million, and RMB 656 million, respectively [2] - The corresponding profits for the same periods were RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The company, Easy Health (02661), has successfully completed its IPO subscription, raising significant interest with a total margin of HKD 62.04 billion and an oversubscription rate of 1029.8 times, indicating strong market demand for its shares [1] Group 1: IPO Details - Easy Health plans to issue 26.54 million shares, with 10% allocated for public offering at a price of HKD 22.68 per share, aiming to raise HKD 600 million [1] - The company anticipates its shares will begin trading on December 23, with CICC and China Merchants Securities International acting as joint sponsors [1] Group 2: Company Background - Established in 2014, Easy Health provides comprehensive health and insurance solutions, including early screening, health management, health insurance, and support for medical research [1] - The company ranks 10th in China's digital integrated health services and health insurance market, and 7th in the digital health services market according to a report by Sullivan [1] Group 3: Financial Information - Easy Health has introduced Aoqin Harmony as a cornerstone investor, committing RMB 100 million, which translates to approximately 4.80 million shares at the IPO price [2] - Projected revenues for Easy Health are approximately RMB 490 million, RMB 945 million, and RMB 656 million for the six months ending June 30 in 2023, 2024, and 2025 respectively, with corresponding profits of RMB 73.62 million, RMB 10.40 million, and RMB 86.05 million [2] Group 4: Use of Proceeds - The net proceeds from the IPO will be allocated as follows: 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for expansion into new regions and overseas markets, and 10% for working capital and general corporate purposes [2]

Core Viewpoint - The successful IPO of Easy Health Group marks a significant transition from a crowdfunding platform to an AI-driven health management company, aiming to enhance its market position and financial performance [1][11]. Group 1: IPO Success Factors - Easy Health Group has transformed itself into an AI health company, moving away from solely selling insurance and focusing on high-margin technology services, with AIcare technology stack and Dr.GPT for smart consultations and chronic disease monitoring [4]. - The company has shown a strong financial recovery, with a compound annual growth rate (CAGR) of 54.9% in revenue from 2022 to 2024, and a revenue of 656 million yuan in the first half of 2025, representing an 84.7% year-on-year increase [4]. - The backing of prominent investors such as IDG Capital, Tencent, and Sunshine Insurance provides validation of Easy Health's business model and future prospects, instilling confidence in potential investors [5]. Group 2: Challenges Ahead - The separation of the major revenue source, the crowdfunding platform "Qing Song Chou," has led to a decline in active users, dropping from 70.5 million in 2022 to 22.7 million in the first half of 2025, a decrease of 26.5% [8]. - The gross margin has significantly decreased from 82.6% in 2022 to 38.3% in 2024, stabilizing around 32.5% in the first half of 2025, indicating potential profitability challenges [8][9]. - The company faces intense competition in both the insurance and digital health service sectors, with rivals like Waterdrop and Ping An Good Doctor, necessitating strategic adaptations to maintain market relevance [9]. Group 3: Future Prospects - The IPO is expected to provide capital for further technological advancements, with plans to raise up to 601 million HKD, allocating 40% for brand building and user engagement, and 20% for AI and big data capabilities [11]. - The successful IPO signifies regulatory and market recognition of Easy Health's dual business model of digital health services and health insurance, suggesting long-term profitability potential [11]. - With the backdrop of the "Healthy China 2030" initiative and the AI healthcare trend, Easy Health Group is positioned for growth, provided it can enhance its user acquisition strategies [11].

Core Viewpoint - QingSong Health (02661.HK) is set to launch its IPO in Hong Kong from December 15 to December 18, 2025, with an expected listing date on December 23, 2025, aiming to raise approximately HKD 6.02 billion [3][4]. Group 1: IPO Details - Total number of shares offered globally is 26,540,000, subject to the exercise of the over-allotment option [2]. - The offering price is set at HKD 22.68 per share, with additional fees including a 1.0% brokerage commission and various transaction fees [2]. - The initial allocation for public offering is 10%, with no mechanism for reallocation [4]. Group 2: Use of Proceeds - The net proceeds from the IPO are estimated to be around HKD 5.13 billion, with allocations as follows: approximately 40% for brand awareness and user engagement, 20% for medical and real-world research, 20% for enhancing AI and big data capabilities, 10% for market expansion, and 10% for working capital and general corporate purposes [5]. Group 3: Shareholder Structure - After the IPO, the controlling shareholder, Ms. Yang Ying, will hold approximately 33.94% of the voting rights through various arrangements [5][6]. - Other notable investors include IDG, Sunshine Insurance, and Tencent, with public shareholders holding 12.86% [5][6]. Group 4: Company Overview - Established in 2014, QingSong Health focuses on providing digital integrated health services and health insurance solutions, ranking 10th in China's digital integrated health services market by revenue in 2024 [6]. - The company offers a variety of personalized health services, including screening, health consultations, medical appointment services, and health product sales [6].

Group 1 - The core viewpoint of the article is that Easy Health (2661.HK) is launching an IPO with a share price of HKD 22.68, aiming to raise up to HKD 601 million [1] - The company is offering 26.54 million shares, with 10% allocated for public offering in Hong Kong and the remainder for international placement [1] - The expected listing date for the stock is December 23 [1] Group 2 - The net proceeds from the IPO will be allocated as follows: approximately 40% for enhancing brand awareness, increasing user engagement, and strengthening partnerships [1] - About 20% of the funds will be used for medical research and real-world studies [1] - Another 20% is designated for improving technological capabilities in AI and big data [1] - 10% will be used for expansion into more regions and overseas markets [1] - The remaining 10% is allocated for working capital and other general corporate purposes [1]